The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer (NSRHCXCA)

Inclusion Criteria:

• Histologically diagnosed cervical cancer
• FIGO stage IA2-IIA
• Diameter of tumor is less than 4cm on exam
• One of hitological type written below squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma
• Age between 18-70
• Performance status; GOG 0-1
• Normal hematological, hepatic, nephrologic function WBC ≥ 4000 cells/mm3 Platelet ≥ 100,000 /mm3 Hemoglobin ≥ 8.0 gm/dL Serum creatinin ≤ 1.3 mg/dL Serum bilirubin ≤ 1.5 mg/dL SBOT/SGPT and Alkaline phoaphatase < normal X 3
• Patient with informed consent

Exclusion creteria:

• Small cell carcinoma
• Unable to perform surgery because of severe underlying medical disease severe heart disease, congestive heart failure/severe pulmonary disease, pulmonary failure/ active bacterial infectio which needs non oral antibiotic therapy/ associated with other severe medical diseases
• Prior chemotherapy or radiotherapy
• Severe bladder funtion abnormality
• Double primary malignant tumor
• Psychiatric problems
• Pregnant or breast feeding status
• Legally unable to participate clinical trial
• When there is a Doctor's decision that patient is unable to participate clinical trial